Internal Medicine · Fairview Park, OH
NPI
1922075399
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
19050 Lorain Rd
Fairview Park, OH, 44126
Phone (216) 252-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$94K
7,707 services
Medicare patients, 2024
292
Average age 75
Drug cost, 2024
$2.1M
14,634 prescriptions
Company payments, 2025
$1,206
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohamed M Shahed was code 99214 (office e&m - established), 364 times for 219 patients. In total Mohamed M Shahed billed 7,707 services in 39 codes, and Medicare paid $94K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 364 | 219 | $44.40 | $16K |
| 99497 Care Management/Coordination | Office | 251 | 241 | $12.77 | $3,206 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 188 | 188 | $26.77 | $5,033 |
| 99215 Office E&M - Established | Office | 132 | 86 | $57.85 | $7,637 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 44 | 19 | $37.81 | $1,664 |
| 99204 Office E&M - New | Office | 26 | 26 | $99.67 | $2,591 |
| 90661 Vaccine Product | Office | 21 | 21 | $36.11 | $758 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 19 | 18 | $56.43 | $1,072 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 15 | 13 | $56.57 | $848 |
| 99213 Office E&M - Established | Office | 11 | 11 | $24.47 | $269 |
By year: 2022 $62K for 3,687 services; 2023 $91K for 6,906 services; 2024 $94K for 7,707 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mohamed M Shahed prescribed most often to Medicare patients was Levothyroxine Sodium, with 787 prescriptions and refills. In total Mohamed M Shahed wrote 14,634 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 787 | 1,995 | 191 | $8,750 |
| Pantoprazole Sodium Generic | 534 | 1,261 | 147 | $7,540 |
| Atorvastatin Calcium Generic | 517 | 1,390 | 143 | $4,455 |
| Rosuvastatin Calcium Generic | 445 | 1,211 | 153 | $5,249 |
| Gabapentin Generic | 441 | 759 | 106 | $5,091 |
| Amlodipine Besylate Generic | 435 | 1,170 | 129 | $1,716 |
| Methylprednisolone Generic | 430 | 430 | 269 | $2,422 |
| Ozempic Semaglutide | 400 | 524 | 81 | $495K |
| Metoprolol Succinate Generic | 302 | 834 | 89 | $3,720 |
| Furosemide Generic | 282 | 668 | 81 | $1,516 |
| Mounjaro Tirzepatide | 271 | 281 | 46 | $290K |
| Valsartan Generic | 264 | 702 | 79 | $6,915 |
| Metformin Hcl Generic | 246 | 638 | 64 | $1,527 |
| Escitalopram Oxalate Generic | 241 | 635 | 71 | $2,831 |
| Lisinopril Generic | 234 | 651 | 71 | $1,424 |
Brand drugs: 2,268 claims; generic drugs: 12,283 claims; opioid claims: 276.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohamed M Shahed $1,206 ($1,206 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $253.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 26 | $253 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $225 |
| Novo Nordisk Inc NVO | 14 | $170 |
| Axsome Therapeutics, Inc. AXSM | 4 | $89.53 |
| Xeris Pharmaceuticals, Inc. | 4 | $87.26 |
| Eisai Inc. 4523.T | 4 | $85.89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73.02 |
| Lilly USA, LLC LLY | 3 | $50.74 |
| Dexcom, Inc. DXCM | 1 | $23.61 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $20.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.